Understanding the potential benefits of adaptive therapy for metastatic melanoma
E. Kim, J. S. Brown, Z. Eroglu, A. R. A. Anderson
This study develops mathematical models to predict adaptive therapy benefits for metastatic melanoma, showing potential delays in progression by 6-25 months compared to continuous therapy.
bioRxiv · Oct 16, 2020 · PreprintCancer Biology